HHS Urges DC Circ. To Keep Ban On OxyContin Misbranders

Law360, New York (October 7, 2011, 5:44 PM EDT) -- The U.S. Department of Health and Human Services on Wednesday asked the District of Columbia Circuit to uphold a 12-year exclusion from federal health programs for three former Purdue Frederick Co. executives who pled guilty to misdemeanors relating to the company's misbranding of the blockbuster painkiller OxyContin.

The three executives, former Purdue President Michael Friedman, former Chief Legal Officer Howard Udell and former Chief Medical Officer Paul D. Goldenheim, are appealing a December decision by a U.S. district judge to uphold the results of HHS' internal...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.